E-viri
PDF
Recenzirano
Odprti dostop
-
Rabe, Klaus F; Nair, Parameswaran; Brusselle, Guy; Maspero, Jorge F; Castro, Mario; Sher, Lawrence; Zhu, Hongjie; Hamilton, Jennifer D; Swanson, Brian N; Khan, Asif; Chao, Jingdong; Staudinger, Heribert; Pirozzi, Gianluca; Antoni, Christian; Amin, Nikhil; Ruddy, Marcella; Akinlade, Bolanle; Graham, Neil M.H; Stahl, Neil; Yancopoulos, George D; Teper, Ariel
The New England journal of medicine, 06/2018, Letnik: 378, Številka: 26Journal Article
Patients who used oral glucocorticoids for asthma were able to reduce the dose of treatment more successfully when dupilumab, a monoclonal antibody targeting signaling through the interleukin-4 and interleukin-13 receptor, was added to their regimen than when placebo was added.
